Kumar Neil bought BBIO
December 12, 2025 · Form 4 insider transaction
Kumar Neil bought 60,975 shares of BridgeBio Pharma, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,975
Price
N/A
Total value
N/A
InsiderKumar Neil
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after289,751
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.